Hepatocyte ABCA1 Deletion Impairs Liver Insulin Signaling and Lipogenesis

Chia-Chi C. Key(Wake Forest University), Mingxia Liu(Wake Forest University), C. Lisa Kurtz(University of North Carolina at Chapel Hill), Soonkyu Chung(University of Nebraska–Lincoln), Elena Boudyguina(Wake Forest University), Timothy A. Dinh(University of North Carolina at Chapel Hill), Alexander C. Bashore(Wake Forest University), Peter E. Phelan(Sanford Burnham Prebys Medical Discovery Institute), Barry I. Freedman(Wake Forest University), Timothy F. Osborne(Sanford Burnham Prebys Medical Discovery Institute), Xuewei Zhu(Wake Forest University), Lijun Ma(Wake Forest University), Praveen Sethupathy(University of North Carolina at Chapel Hill), Sudha B. Biddinger(Boston Children's Hospital), John S. Parks(Wake Forest University)
Cell Reports
June 1, 2017
Cited by 37Open Access
Full Text

Abstract

Plasma membrane (PM) free cholesterol (FC) is emerging as an important modulator of signal transduction. Here, we show that hepatocyte-specific knockout (HSKO) of the cellular FC exporter, ATP-binding cassette transporter A1 (ABCA1), leads to decreased PM FC content and defective trafficking of lysosomal FC to the PM. Compared with controls, chow-fed HSKO mice had reduced hepatic (1) insulin-stimulated Akt phosphorylation, (2) activation of the lipogenic transcription factor Sterol Regulatory Element Binding Protein (SREBP)-1c, and (3) lipogenic gene expression. Consequently, Western-type diet-fed HSKO mice were protected from steatosis. Surprisingly, HSKO mice had intact glucose metabolism; they showed normal gluconeogenic gene suppression in response to re-feeding and normal glucose and insulin tolerance. We conclude that: (1) ABCA1 maintains optimal hepatocyte PM FC, through intracellular FC trafficking, for efficient insulin signaling; and (2) hepatocyte ABCA1 deletion produces a form of selective insulin resistance so that lipogenesis is suppressed but glucose metabolism remains normal.


Related Papers